Thursday, March 21, 2024

A new Covid origin inquiry is bipartisan

Presented by 340B Health: The ideas and innovators shaping health care
Mar 21, 2024 View in browser
 
Future Pulse

By Erin Schumaker, Daniel Payne and Ruth Reader

Presented by 340B Health

WASHINGTON WATCH

Michael Rampangilei (2nd R), Legacy Lead of ASEAN One Shot Campaign, speaks in front of the projected image of covid-19 coronavirus during the ASEAN Business and Investment Summit 2023  ahead of the ASEAN Summit in Jakarta on September 5, 2023. (Photo by Yasuyoshi CHIBA / AFP) (Photo by YASUYOSHI CHIBA/AFP via Getty Images)

A bipartisan Senate duo will take another stab at solving the Covid origin mystery. | AFP via Getty Images

Sen. Rand Paul (R-Ky.), who sparred with top public health officials in heated hearings about Covid-19 and the government’s response to the pandemic, has found a Democrat to join him in investigating the virus' origins.

And it’s not just any Democrat. It’s Gary Peters (D-Mich.), chair of the Senate Homeland Security and Governmental Affairs Committee on which Paul is the ranking Republican.

The duo announced yesterday they are investigating where Covid came from, the high-risk research that Paul believes caused the pandemic, as well as broader "national security threats posed by high-risk biological research and technology.”

Why it matters: Lawmakers on both sides of the aisle are concerned about risky research.

President Joe Biden, in his October executive order on artificial intelligence, tasked government agencies with laying the groundwork for new rules and requirements for how AI will be used in synthetic biology, the creation or modification of organisms.

The collaboration between Paul and Peters also means more scrutiny for government scientists. Earlier this month, the Homeland Security panel unanimously approved Paul’s bill to require government scientists to disclose royalties they receive from companies and make public the financial disclosure forms filed by members of federal scientific advisory committees.

Paul has butted heads with officials at the National Institutes of Health, the world's biggest funder of biomedical research — particularly Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases — over how the agency handled the pandemic and its research on Covid's origins.

While Peters and Paul might seem like an unlikely investigative pairing, the Homeland Security committee advanced Peters’ bill earlier this month that aims to keep Americans' genetic data safe from foreign adversaries. In 2022, Peters released a report into the initial Covid-19 reponse, which found that the federal response by the Trump administration didn't "reflect the severity of the crisis and ultimately failed to effectively mitigate the spread of COVID-19."

What’s next? Peters and Paul said they plan to:

— Hold hearings on high-risk life science research, biodefense, synthetic biology, biosafety and biosecurity lapses, early warnings for emerging disease outbreaks and the origins of Covid-19

— Assess and measure risk from deliberate, accidental and natural biological incidents

— Increase transparency and strengthen oversight of taxpayer-funded life science research.

 

A message from 340B Health:

Support the 340B PATIENTS Act The 340B PATIENTS Act eliminates harmful big pharma restrictions on 340B savings that are vital for expanding health care and support for patients and rural communities in need. By restricting 340B pharmacy partnerships, drugmakers have siphoned billions from the health care safety net solely to bolster their profits. The 340B PATIENTS Act stops this damaging behavior. We call on Congress to support this vital legislation. Learn more.

 
WELCOME TO FUTURE PULSE

National Arboretum, Washington, D.C.

National Arboretum, Washington, D.C. | Shawn Zeller/POLITICO

This is where we explore the ideas and innovators shaping health care.

Relax, you don't need to don the lead vest at the dental office anymore. The American Dental Association says current X-ray technology is safe enough to dispense with it.

Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Ruth Reader at rreader@politico.com or Erin Schumaker at eschumaker@politico.com.

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.  

 

A message from 340B Health:

Advertisement Image

 
FORWARD THINKING

ln this photo taken Wednesday Sept. 14, 2011, Dr. Karen Lindsfor, a professor of radiology and chief of breast imaging at the University of California, Davis Medical Center, examines the mammogram of a patient with heterogeneously dense breast tissue, in Sacramento, Calif. Lindfors opposes a measure approved by the state Legislature earlier this month, that would require health facilities performing mammograms to notify patients with dense tissue that they may want to   receive additional screenings. Lindfors is among those doctors who say there was insufficient evidence to support the idea that additional screenings would detect cancers earlier. (AP Photo/Rich Pedroncelli)

AI's showing it can see things the human eye cannot. | AP

Advanced artificial intelligence models built with large datasets could bring “unprecedented advancements” to medicine, researchers at Mass General Brigham believe.

They built two of the so-called foundation models, focused on applications in pathology, and published some of their findings this week in Nature Medicine.

How so? They trained one of the models, UNI, on more than 100 million tissue patches and over 100,000 whole-slide images.

The researchers gave UNI 34 tasks — including cancer diagnosis and organ transplant assessments — and it outperformed current pathology models.

They trained the second model, CONCH, on more than 1 million images with captions. Its text training enables pathologists to search for examples of diseases of interest. It outperformed traditional models in 14 tasks, the researchers said.

Future impacts: UNI and CONCH show promise where other models have struggled, the researchers said, including analyzing diseases that are rare or traditionally difficult to identify.

And their success could be good news for even more applications.

“Foundation models represent a new paradigm in medical artificial intelligence,” Faisal Mahmood, one of the researchers, said in a statement. “These models are AI systems that can be adapted to many downstream, clinically relevant tasks. We hope that the proof-of-concept presented in these studies will set the stage for such self-supervised and multimodal large language models to be trained on larger and more diverse datasets.”

 

A message from 340B Health:

Support the 340B PATIENTS Act

340B hospitals are the backbone of the nation’s health care safety net, providing essential services to patients with low incomes and those living in rural America. 340B hospitals play a vital role in delivering 77% of Medicaid hospital care, providing 67% of the nation’s unpaid care, and offering comprehensive specialty services that otherwise might not be available. 340B helps lower health care costs and enable doctors, nurses, and pharmacists to provide expanded care for the benefit of their community—all at no cost to the taxpayer.

The 340B PATIENTS Act will end harmful drug company restrictions on 340B savings that are vital for protecting patients and communities. By restricting 340B pharmacy partnerships, big pharma has siphoned billions from the health care safety net solely to bolster its profits. The 340B PATIENTS Act stops this damaging behavior. We call on Congress to support this vital legislation. Learn more.

 
 

YOUR GUIDE TO EMPIRE STATE POLITICS: From the newsroom that doesn’t sleep, POLITICO's New York Playbook is the ultimate guide for power players navigating the intricate landscape of Empire State politics. Stay ahead of the curve with the latest and most important stories from Albany, New York City and around the state, with in-depth, original reporting to stay ahead of policy trends and political developments. Subscribe now to keep up with the daily hustle and bustle of NY politics. 

 
 
SAFETY CHECK

A 911 dispatcher.

911 dispatchers are first responders for many people in mental health crisis. | AP Photo/Tim Roske

Many people still call 911 for help when someone is having a mental health crisis, according to a new report from the RAND Corporation think tank.

That’s not ideal, since the Biden administration wants them to call 988, the national suicide and crisis lifeline it launched in 2022.

Since many people aren’t aware of 988, the researchers say, authorities should seek to ensure the two services coordinate.

More than half of people in the U.S. are unfamiliar with 988, according to a separate 2023 study. When 988 launched, fewer than half of state and county behavioral health directors had a plan prepared and only two-thirds included some coordination between 911 and 988, according to RAND data.

While 95 percent of 988 calls are resolved on the phone, a small percentage still require an in-person response. RAND reports that it’s important for emergency services and the crisis line to work from the same playbook and be able to transfer callers.

What does that look like? 

— Coordination between 988 and 911 units: RAND looked at three jurisdictions that designed models for when to divert callers to 988 or decide whether a 911 responder should send a social worker, law enforcement or both in person. The jurisdictions were Minnehaha County, S.D.; Orange County, N.Y.; and Fairfax County, Va.

—  Co-location: The report found that in some cases, collaboration between teams was easier when they worked from the same office.

Peer support: In addition to training law enforcement to handle behavioral health issues or having a team of mental health professionals on standby to help a person in crisis, communities should consider enlisting individuals who have considered suicide themselves to respond to callers experiencing suicidal ideation.

What’s next? RAND says states should consider rules that require the two services work together.

 

Easily connect with the right N.Y. State influencers and foster the right relationships to champion your policy priorities. POLITICO Pro. Inside New York. Learn more.

 
 
 

Follow us on Twitter

Carmen Paun @carmenpaun

Daniel Payne @_daniel_payne

Ruth Reader @RuthReader

Erin Schumaker @erinlschumaker

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

No comments:

Post a Comment

7 Best Stocks for the Next 30 Days

Free from Zacks Investment Research  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌...